skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi Peter and Ryan,

With interest rates going up next month would like to know your thoughts on the short term effect this will have on the above tech companies, will there be a discount after the rates rise.

As always
Thank you
Anthony
Read Answer Asked by Anthony on February 17, 2022
Q: Dear 5i,
I would appreciate your current thoughts on MHC.U?
In earlier posts you mentioned that their 15x Cash Flow was expensive.
What would be a good value Cash Flow to purchase this stock at?
What is the current Cash Flow and where can I find future Cash Flow metrics? Can you suggest other investable companies in this space other than CAR.UN and BAM? Thanks so much!
Read Answer Asked by Ian on February 17, 2022
Q: I have used hfr to park cash for several years. With rates about to rise I want to park some additional cash there but wondering if there is/are other short-term note etfs you can recommend for comparison.

Thanks very much.

Mike
Read Answer Asked by Michael on February 17, 2022
Q: Hello 5I team: At one point I was down 87% on vet.Some how I had the conviction to hold. Now today when it broke 23$ I was finally ahead . Do you foresee enough upside potential for me to continue to hold and make back some of my grief or could you see a switch with more less risky upside.Lots of noise about 100$ oil. Appreciate very much your input and tks.Larry
Read Answer Asked by Larry on February 17, 2022
Q: My position in ROKU has decreased to less than 1% with the losses it has taken from the highs (bought at $353/share). Would you recommend adding to it at these levels? How expensive is it right now? Is it at the high end of its peers? I am comfortable with risk, is held within my TFSA, and looking 5+ years hold.
Read Answer Asked by Justin on February 17, 2022
Q: It feels like a gut punch. Down 20% today. Down 60% for 90 days ago. Sentiment is negative. It is now rated as Moderate Buy with 7 buy ratings and 5 hold (Tipranks).

A number of analysts have not rerated yet cause the earnings are so fresh.

The Balanced portfolio is now down +25% since inception of the position.

I am afraid (little late I guess) that the stock, not necessarily the company is broken.

I do not see a short to intermediate term catalyst that will turn this freight train around and just thinking, Where Are the Opportunities Now?


Sorry, still in a little daze about the drastic decline of this position. Not sure what to do at this point?


Sheldon
Read Answer Asked by Sheldon on February 17, 2022
Q: What are your thoughts on the earnings. I hold stock in my account and joint account. Both are in Cash account.

Tax Purpose - When I sell do I need to Average combine both accounts. Or I need to report profit separately since one is in joint account and another my own account.

Thanks for the great service
Read Answer Asked by Hector on February 17, 2022
Q: what are your top three picks ,us and cdn, for consumer staples thanks
Read Answer Asked by andre on February 17, 2022
Q: Your top 10 US growth stocks please. Thanks.
Read Answer Asked by Peter on February 17, 2022
Q: Both of these health care stocks fell significantly after reporting what appear to be decent earnings. They are both expensive -- less so now -- and high valuation stocks are currently being punished. But the drops seem overly harsh. Could you please comment on their earnings and guidance. Is this a good time to buy? Thanks.
Read Answer Asked by Ron on February 17, 2022
Q: Hi Peter and 5i,
Would you please comment on GRMN earnings?
With regards to their future guidance for next year - Sales $5.0B up to $5.5B, GM% - 57.5% down from 58.0% (also down more so from previous years), Pro forma EPS $5.90 basically the same as this year at $5.82.
I like their $3.1B cash position.
Do you think supply chain issues are the main driver for their GM% reductions and thus their EPS in 2022 guidance? And do you see GRMN returning to their steady growth (single and sometimes low double digit) beyond 2022 and would you continue to hold this stock for the long term (5 years +)?
Read Answer Asked by Dennis on February 17, 2022
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!